Wednesday, October 8, 2025

10:15 - 11:00

SEVERO OCHOA ROOM

---

Overview

Sponsor: KLINEA BIOTECH & PHARMA ENGINEERING

---

Details

In recent decades, biotechnology has established itself as one of the most transformative forces in the pharmaceutical industry. No longer limited to the realm of research, it now plays a central role in the development, production, and commercialization of many of today’s most innovative and effective therapies. Biologic drugs, once considered niche products, now dominate global sales rankings, with more than half of the top 20 best-selling medicines being biotechnology-based. This is no longer an emerging trend, but a firmly established reality. In this roundtable, we will examine the evolution of biological drugs, from the first recombinant products such as insulin to the latest generation of advanced therapies. This historical overview will be followed by an analysis of the current landscape: the growing presence of biotech in development pipelines, its strategic importance, and the shifting priorities in R&D. We will also explore a key turning point for the industry: the expiration of patents for major biologics and the resulting rise of biosimilars. This phenomenon not only opens up new business opportunities but also redefines global market dynamics. Finally, we will look ahead to the biotechnological innovations that are set to shape the future: What therapies are on the horizon? How will regulatory, economic, and technological factors influence their development and accessibility?

---

Details